Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, ...

Novartis has done a little spring cleaning, sweeping a phase 2 osteoarthritis prospect and first-in-human radioconjugate out of its pipeline after assessing evidence on the programs. The actions ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals get in the way of its progress. With recent indication additions, breast ...

With strong positions in multiple key therapeutic areas, Novartis is well positioned for steady long-term cash flows. Strong intellectual property supporting multibillion-dollar products ...

Novartis NOVN-0.45%decrease; red down pointing triangle raised its 2025 outlook after high demand for key drugs drove first-quarter profit and sales above expectations, becoming the first among ...

Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance. Net sales were up 15% on a constant currency basis to $13.2 ...

Novartis schlägt Gewinnerwartungen, erhöht Prognose Quartalsgewinn stieg um 23%, übertraf Analystenschätzungen Konkurrenz durch billigere Generika droht dieses Jahr ...

Swiss drug firm Novartis reported on Tuesday that it had generated a better-than-expected profit in the first three months of the year. Net sales were up 15% on a constant currency basis to $13.2 ...

BASEL, Switzerland (AP) — BASEL, Switzerland (AP) — Novartis AG (NVS) on Tuesday reported first-quarter net income of $3.61 billion. On a per-share basis, the Basel, Switzerland-based company ...

Get local news you need to know to start your day with NBC 6's News Headlines newsletter. Novartis also raised its full-year guidance for 2025, forecasting net sales to grow by high single ...

Novartis also raised its full-year guidance for 2025, forecasting net sales to grow by high single digits and core operating income to increase by low double-digits. The results come as the ...

Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance. Stream NBC 5 for free, 24/7, wherever you are. Net sales were ...